GI startup raises $30M

Iterative Scopes bagged $30 million in series A funding to develop its artificial intelligence-powered gastroenterology and drug development technology, according to BioWorld. The startup landed investments from Obvious Ventures, Eli Lilly, Johnson & Johnson Innovation-JJDC, and venture capital firms Breyer Capital and Seae Ventures.

Advertisement

Iterative Scopes’ algorithms currently offer two applications — one that assists clinicians in detecting polyps and another that uses colonoscopy images to help physicians determine a given patient’s clinical trial eligibility.
The Cambridge, Mass.-based startup, born out of the Massachusetts Institute of Technology in 2017, has raised $43.5 million over nine rounds of funding.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.